Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F L Hall

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Oncogene|July 1, 1993
Increased cyclin A and decreased cyclin D levels in adenovirus 5 E1A-transformed rodent cell linesT Buchou, O Kranenburg, H van Dam, et al.
Human Gene Therapy|July 7, 2001
Lesion-targeted injectable vectors for vascular restenosisE M Gordon, N L Zhu, M Forney Prescott, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2011
Prognosis of patients with breast cancer: causes of death and effects of time since diagnosis, age, and tumor characteristicsEdoardo Colzani, Annelie Liljegren, Anna L V Johansson, et al.
The Biochemical Journal|May 15, 1996
Transforming growth factor-beta type-II receptor signalling: intrinsic/associated casein kinase activity, receptor interactions and functional effects of blocking antibodiesF L Hall, P D Benya, S R Padilla, et al.
Oncogene|May 1, 1993
Two potentially oncogenic cyclins, cyclin A and cyclin D1, share common properties of subunit configuration, tyrosine phosphorylation and physical association with the Rb proteinF L Hall, R T Williams, L Wu, et al.
International Journal of Molecular Medicine|June 16, 2001
Long term inhibition of neointima formation in balloon-injured rat arteries by intraluminal instillation of a matrix-targeted retroviral vector bearing a cytocidal mutant cyclin G1 constructF Xu, M F Prescott, P X Liu, et al.
Human Gene Therapy|May 16, 2000
Molecular engineering of matrix-targeted retroviral vectors incorporating a surveillance function inherent in von Willebrand factorF L Hall, L Liu, N L Zhu, et al.
American Journal of Respiratory Cell and Molecular Biology|August 1, 1993
Cyclin A expression in normal and transformed alveolar epithelial cellsK C Bui, F Wu, S Buckley, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 1996
Factor XII-induced mitogenesis is mediated via a distinct signal transduction pathway that activates a mitogen-activated protein kinaseE M Gordon, N Venkatesan, R Salazar, et al.
Circulation|July 15, 1997
Downregulation of cyclin G1 expression by retrovirus-mediated antisense gene transfer inhibits vascular smooth muscle cell proliferation and neointima formationN L Zhu, L Wu, P X Liu, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Oncogene|July 1, 1993
Increased cyclin A and decreased cyclin D levels in adenovirus 5 E1A-transformed rodent cell linesT Buchou, O Kranenburg, H van Dam, et al.
Human Gene Therapy|July 7, 2001
Lesion-targeted injectable vectors for vascular restenosisE M Gordon, N L Zhu, M Forney Prescott, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2011
Prognosis of patients with breast cancer: causes of death and effects of time since diagnosis, age, and tumor characteristicsEdoardo Colzani, Annelie Liljegren, Anna L V Johansson, et al.
The Biochemical Journal|May 15, 1996
Transforming growth factor-beta type-II receptor signalling: intrinsic/associated casein kinase activity, receptor interactions and functional effects of blocking antibodiesF L Hall, P D Benya, S R Padilla, et al.
Oncogene|May 1, 1993
Two potentially oncogenic cyclins, cyclin A and cyclin D1, share common properties of subunit configuration, tyrosine phosphorylation and physical association with the Rb proteinF L Hall, R T Williams, L Wu, et al.
International Journal of Molecular Medicine|June 16, 2001
Long term inhibition of neointima formation in balloon-injured rat arteries by intraluminal instillation of a matrix-targeted retroviral vector bearing a cytocidal mutant cyclin G1 constructF Xu, M F Prescott, P X Liu, et al.
Human Gene Therapy|May 16, 2000
Molecular engineering of matrix-targeted retroviral vectors incorporating a surveillance function inherent in von Willebrand factorF L Hall, L Liu, N L Zhu, et al.
American Journal of Respiratory Cell and Molecular Biology|August 1, 1993
Cyclin A expression in normal and transformed alveolar epithelial cellsK C Bui, F Wu, S Buckley, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 1996
Factor XII-induced mitogenesis is mediated via a distinct signal transduction pathway that activates a mitogen-activated protein kinaseE M Gordon, N Venkatesan, R Salazar, et al.
Circulation|July 15, 1997
Downregulation of cyclin G1 expression by retrovirus-mediated antisense gene transfer inhibits vascular smooth muscle cell proliferation and neointima formationN L Zhu, L Wu, P X Liu, et al.
Pageof 7